NCT02652923View on ClinicalTrials.gov

Contrast Ultrasound Detection of Sentinel Lymph Nodes

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

January 12, 2022

Study Completion Date

January 12, 2022

Conditions
Breast Cancer
Interventions
DRUG

Sonazoid; Perflubutane for Injection

subdermal injection into the breast of Sonazoid (1 or 2 ml) divided into four individual aliquots at four locations (12, 3, 6, and 9 o'clock)

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

GE Healthcare

INDUSTRY

collaborator

Siemens Medical Solutions

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER